Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Medicine information APEXXNAR suspension for injection in pre-filled syringe
- Product code:
- W68478002
- Quantity:
- 1
- Indicated for:
- prevention of pneumococcal disease
- Route of administration:
- injectable
- Substance:
- 20-valent adsorbed conjugated polysaccharide pneumococcal vaccine (vaccine)
- ATC
- J07AL02 — Antiinfectives for systemic use | Bacterial vaccines | Pneumococcal vaccines
The 20-valent adsorbed pneumococcal polysaccharide conjugate vaccine is designed to protect against infections caused by 20 different serotypes of the Streptococcus pneumoniae bacterium. It is used to prevent invasive pneumococcal diseases such as pneumonia, meningitis, and sepsis, as well as otitis media, particularly in high-risk groups such as young children, the elderly, and individuals with chronic conditions or immunosuppression.
This vaccine is a conjugate and adsorbed product, meaning that the capsular polysaccharides of the bacterium are linked to a carrier protein and fixed onto an adjuvant (usually aluminum hydroxide). This combination enhances the immune response, increasing the vaccine's effectiveness, especially in children under 2 years old and individuals with weakened immune systems.
The vaccine is administered via intramuscular injection according to a vaccination schedule established by public health authorities. It is well-tolerated, but mild side effects such as pain at the injection site, fever, fatigue, or irritability may occur. Severe reactions, such as allergic responses, are rare.
Following the recommended vaccination schedule is essential to ensure optimal protection against pneumococcal diseases.
This vaccine is a conjugate and adsorbed product, meaning that the capsular polysaccharides of the bacterium are linked to a carrier protein and fixed onto an adjuvant (usually aluminum hydroxide). This combination enhances the immune response, increasing the vaccine's effectiveness, especially in children under 2 years old and individuals with weakened immune systems.
The vaccine is administered via intramuscular injection according to a vaccination schedule established by public health authorities. It is well-tolerated, but mild side effects such as pain at the injection site, fever, fatigue, or irritability may occur. Severe reactions, such as allergic responses, are rare.
Following the recommended vaccination schedule is essential to ensure optimal protection against pneumococcal diseases.
General data about APEXXNAR
- Substance:
- 20-valent adsorbed conjugated polysaccharide pneumococcal vaccine
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W68478002
- Pharmaceutical form:
- suspension for injection in pre-filled syringe
- Quantity:
- 1
- Product type:
- Original
- Prescription status:
- P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Official documents
The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- EMA
- Document language
- English
- Source record: first published
- 02/03/2022
- Source record: last updated
- 18/11/2025
Warnings:
Additional monitoring
This medicine is subject to additional monitoring.
Refrigerated storage
Store in the refrigerator as instructed in the leaflet.
Protect from light
Store protected from light.